The domestic market encounters warm current drugs to usher in spring
Release time: 2012-02-14 & nbsp & nbsp & nbsp Source:
Recent，Hunan Erkang Pharmaceutical, who was listed on the GEM for less than half a year old, was recommended by many securities institutions。Xiangcai Securities、Donghai Securities and other institutions have released research reports to be optimistic about their growth。February 2，Shenzhen Hongling Private Equity Fire Layout Erkang Pharmaceutical。Reporters found that when analyzing this popular capital incident，Industrial investors represented by the above institutions currently have a common value orientation: there is a single clock for high -end pharmaceutical auxiliary materials。
Actually，With the prevalence of the domestic environmental protection trend，The quality of the drug is continuously improved and the international market brought by the "patented cliff" high -end medicinal auxiliary materials、Increase in demand for new materials，Medicinal accessories may usher in spring。"There is still a gap between the quality of domestic generic drugs and the original drug，Accessories My stake betting appare stake betting appalso one of the most important reasons。With the increase in the strength of China's promoting brand generic drugs，The demand for high -quality auxiliary materials will rise。"Yu Mingde, chairman of the China Medical Enterprise Management Association, believes。
Demand pull
According to the reporter's understanding，At present, there are about 500 commonly used drugs in my country，The market size of the medicinal auxiliary materials accounts for about 10%of the cost of the entire preparation product。Data released by the Ministry of Industry and Information Technology，2009，The cumulative sales output value of the chemical drug preparation industry has achieved a total sales value of 276.5 billion yuan，Biological Biochemical Products Manufacturing Industry completed 88.7 billion yuan，China Pharmaceutical Manufacturing Industry completed 199.8 billion yuan。Calculated according to this，In 2009, the sales value of domestic pharmaceutical accessories was about 6 billion yuan，2010 around 7 billion yuan。
"Whether it is the expansion of the indication range，Still change the way to administer、Enhance the target control effect，It is inseparable from medicinal auxiliary materials，Some new high -end pharmaceutical accessories or materials are even often become the core technology。"Yu Mingde analyzed the way in an interview with reporters，At present, the mainstream view in the world thinks，Breaking the bottleneck of preparation production、The way to improve the added value of the product is targeted、Control release、absorption, etc.，Most of these breakthrough points need to be achieved with the help of medicinal auxiliary materials。
Erkang Pharmaceutical Recently is highly sought after is the best evidence。The reporter saw it from the company's performance in the past 3 years，Erkang stake sports betting appPharmaceutical stake betting apphas developed many advanced technologies，such as chemical aldehydes、Super filter technology, etc.，Makes its auxiliary materials products that ensure the safety of the drug owner，Multi -component systems that must be possessed not to destroy the best effect of medicinal auxiliary materials。"Drives by the needs of market demand at home and abroad，This company's net profit in the past three years has increased by 109.79%, respectively、192.13%and 78%。"Xiangcai Securities Pharmaceutical Analysts are optimistic about the future pharmaceutical auxiliary materials market。
Another thrust is an upgrade of national quality standards。There are more than 1,000 kinds of foreign medicinal auxiliary materials，and the standard for the drug standards of the National Pharmaceutical Pharmaceutical or Drug Standard is continuously increased。Take the variety of "American Pharmacopoeia" as an example，1990 Edition 345 species，The 2000 version of 650 types are collected; the 2010 version of "Chinese Pharmacopoeia" version of the pharmaceutical auxiliary material standards tend to be specific、Strict，After the supplementation, my country's auxiliary materials standards have reached more than 200 kinds。"Compared to，There are many jobs to improve the standard of accessories，and some indicators in the new standards tend to be strict，Will eliminate a group of low -level companies，Then make a part of the market。More importantly，It will also guide many companies to improve preparation process and medicinal auxiliary materials，It also provides opportunities for the medicinal auxiliary materials market。"The director of Liu Xuebin, Guangzhou Baiyunshan Chemical Pharmaceutical Factory, said to reporters，Another，With the increase of OEM production，Foreign -funded enterprises will stake online sports bettinggradually stake betting apprelease high -quality medicinal auxiliary materials。
Warm spring breakout
Interesting the trend，However, there is a common problem in the pharmaceutical auxiliary materials industry, but it has always plagued the development of enterprise: At present, the size of domestic pharmaceutical auxiliary materials enterprises is small，There are few companies with sales over 100 million yuan。This，Yin Zhenglong, chairman of Anhui Shanhe Pharmaceutical Accessories Co., Ltd.。He thinks，Small、low、San and product homogeneity is the fundamental obstacle to embrace spring。"Standard lack，Product registration is difficult，To a certain extent, it also hinders the introduction and development of new products，Not conducive to the rapid growth of excellent enterprises。"" In the interview，Reporter noticed，APIP is particularly obvious when the medicinal auxiliary materials are restricted by medicinal auxiliary materials。In the United States，A raw material can produce 30 kinds of preparations，my country can only produce 3 types，At present, most of the high -end varieties in my country need to be imported。
Visible，Strong body and fitness have become the first priority in the current domestic pharmaceutical auxiliary materials industry。
Now，DMF file management method has been implemented abroad for many years，This management method is being accepted and prepared to adopt。According to disclosure，my country's DMF file management has entered the final solicitation stage。This，Some experts make suggestions: "DMF file management system should be voluntary declaration，No compulsory，Therefore, the enterprise is deeply recognized; a good institutional design is required，To ensure the informative information，To solve the filing and review、Volunteer and compulsory relationship; my country implements stake online sports bettingstake sports betting appDMF file management，Both foreign experience，It is also necessary to meet China's national conditions; further study the relationship between supplier audit and drug supervision inspection。”
Yu Mingde thinks，Introduction of this new system，It will use new technologies for pharmaceutical auxiliary materials production enterprises、Administrative procedures for adding new performance of medicinal auxiliary materials are more simple。"Future medicinal auxiliary materials industry pays attention to the medicinal auxiliary materials used by Chinese medicine preparations，It may become an important direction for the development of the industry。Enterprises should actively carry out the research of pharmaceutical accessories and pharmaceutical compatibility and safety evaluation，Further improve its quality and technical content。"(Author: Ma Fei)
Actually，With the prevalence of the domestic environmental protection trend，The quality of the drug is continuously improved and the international market brought by the "patented cliff" high -end medicinal auxiliary materials、Increase in demand for new materials，Medicinal accessories may usher in spring。"There is still a gap between the quality of domestic generic drugs and the original drug，Accessories My stake betting appare stake betting appalso one of the most important reasons。With the increase in the strength of China's promoting brand generic drugs，The demand for high -quality auxiliary materials will rise。"Yu Mingde, chairman of the China Medical Enterprise Management Association, believes。
Demand pull
According to the reporter's understanding，At present, there are about 500 commonly used drugs in my country，The market size of the medicinal auxiliary materials accounts for about 10%of the cost of the entire preparation product。Data released by the Ministry of Industry and Information Technology，2009，The cumulative sales output value of the chemical drug preparation industry has achieved a total sales value of 276.5 billion yuan，Biological Biochemical Products Manufacturing Industry completed 88.7 billion yuan，China Pharmaceutical Manufacturing Industry completed 199.8 billion yuan。Calculated according to this，In 2009, the sales value of domestic pharmaceutical accessories was about 6 billion yuan，2010 around 7 billion yuan。
"Whether it is the expansion of the indication range，Still change the way to administer、Enhance the target control effect，It is inseparable from medicinal auxiliary materials，Some new high -end pharmaceutical accessories or materials are even often become the core technology。"Yu Mingde analyzed the way in an interview with reporters，At present, the mainstream view in the world thinks，Breaking the bottleneck of preparation production、The way to improve the added value of the product is targeted、Control release、absorption, etc.，Most of these breakthrough points need to be achieved with the help of medicinal auxiliary materials。
Erkang Pharmaceutical Recently is highly sought after is the best evidence。The reporter saw it from the company's performance in the past 3 years，Erkang stake sports betting appPharmaceutical stake betting apphas developed many advanced technologies，such as chemical aldehydes、Super filter technology, etc.，Makes its auxiliary materials products that ensure the safety of the drug owner，Multi -component systems that must be possessed not to destroy the best effect of medicinal auxiliary materials。"Drives by the needs of market demand at home and abroad，This company's net profit in the past three years has increased by 109.79%, respectively、192.13%and 78%。"Xiangcai Securities Pharmaceutical Analysts are optimistic about the future pharmaceutical auxiliary materials market。
Another thrust is an upgrade of national quality standards。There are more than 1,000 kinds of foreign medicinal auxiliary materials，and the standard for the drug standards of the National Pharmaceutical Pharmaceutical or Drug Standard is continuously increased。Take the variety of "American Pharmacopoeia" as an example，1990 Edition 345 species，The 2000 version of 650 types are collected; the 2010 version of "Chinese Pharmacopoeia" version of the pharmaceutical auxiliary material standards tend to be specific、Strict，After the supplementation, my country's auxiliary materials standards have reached more than 200 kinds。"Compared to，There are many jobs to improve the standard of accessories，and some indicators in the new standards tend to be strict，Will eliminate a group of low -level companies，Then make a part of the market。More importantly，It will also guide many companies to improve preparation process and medicinal auxiliary materials，It also provides opportunities for the medicinal auxiliary materials market。"The director of Liu Xuebin, Guangzhou Baiyunshan Chemical Pharmaceutical Factory, said to reporters，Another，With the increase of OEM production，Foreign -funded enterprises will stake online sports bettinggradually stake betting apprelease high -quality medicinal auxiliary materials。
Warm spring breakout
Interesting the trend，However, there is a common problem in the pharmaceutical auxiliary materials industry, but it has always plagued the development of enterprise: At present, the size of domestic pharmaceutical auxiliary materials enterprises is small，There are few companies with sales over 100 million yuan。This，Yin Zhenglong, chairman of Anhui Shanhe Pharmaceutical Accessories Co., Ltd.。He thinks，Small、low、San and product homogeneity is the fundamental obstacle to embrace spring。"Standard lack，Product registration is difficult，To a certain extent, it also hinders the introduction and development of new products，Not conducive to the rapid growth of excellent enterprises。"" In the interview，Reporter noticed，APIP is particularly obvious when the medicinal auxiliary materials are restricted by medicinal auxiliary materials。In the United States，A raw material can produce 30 kinds of preparations，my country can only produce 3 types，At present, most of the high -end varieties in my country need to be imported。
Visible，Strong body and fitness have become the first priority in the current domestic pharmaceutical auxiliary materials industry。
Now，DMF file management method has been implemented abroad for many years，This management method is being accepted and prepared to adopt。According to disclosure，my country's DMF file management has entered the final solicitation stage。This，Some experts make suggestions: "DMF file management system should be voluntary declaration，No compulsory，Therefore, the enterprise is deeply recognized; a good institutional design is required，To ensure the informative information，To solve the filing and review、Volunteer and compulsory relationship; my country implements stake online sports bettingstake sports betting appDMF file management，Both foreign experience，It is also necessary to meet China's national conditions; further study the relationship between supplier audit and drug supervision inspection。”
Yu Mingde thinks，Introduction of this new system，It will use new technologies for pharmaceutical auxiliary materials production enterprises、Administrative procedures for adding new performance of medicinal auxiliary materials are more simple。"Future medicinal auxiliary materials industry pays attention to the medicinal auxiliary materials used by Chinese medicine preparations，It may become an important direction for the development of the industry。Enterprises should actively carry out the research of pharmaceutical accessories and pharmaceutical compatibility and safety evaluation，Further improve its quality and technical content。"(Author: Ma Fei)
